Atlas Trials

Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic Neuropathy

Clinical trial NCT00857623 · COMPLETED

Trial details

NCT number
NCT00857623
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
PainDiabetic Neuropathy
Start date
2009-02-01
Primary completion
2009-08-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.